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Abstract
Background: Self-treatment of acute exacerbations of COPD with antibiotics and/or oral corticosteroids has emerged as
a promising strategy to reduce hospitalization rates, mortality and health costs. However, for reasons little understood, the
effect of self-treatment, particularly when not part of comprehensive self-management programs, remains
unclear. Therefore, this study aims to get insight into the patients’ perspective on self-treatment of acute
exacerbations of COPD, focusing specifically on how patients decide for the right moment to start treatment with
antibiotics and/or oral corticosteroids, what they consider important when making this decision and aspects which
might interfere with successful implementation.
Methods: We interviewed 19 patients with chronic obstructive pulmonary disease using qualitative semi-structured
interviews, and applied thematic analysis for data analysis.
Results: Patients were well equipped with experiential knowledge to recognize and promptly respond to worsening
COPD symptoms. Worries regarding potential adverse effects of antibiotics and oral corticosteroids played an
important role in the decision to start treatment and could result in hesitation to start treatment. Although self-
treatment represented a practical and appreciated option for some patients with predictable symptom patterns
and treatment effect, all patients favoured assistance from a medical professional when their perceived competence
reached its limits. However, a feeling of obligation to succeed with self-treatment or distrust in their doctors or the
health care system could keep patients from timely help seeking.
Conclusion: COPD patients regard self-treatment of exacerbations with antibiotics and/or oral corticosteroids
as a valuable alternative. How they engage in self-treatment depends on their concerns regarding the medications’
adverse effects as well as on their understanding of and preferences for self-treatment as a means of health
care. Caregivers should address these perspectives in a collaborative approach when offering COPD patients
the opportunity for self-treatment of exacerbations.
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Background
Chronic obstructive pulmonary disease (COPD) is a leading
cause of morbidity and mortality, associated with a
considerable economic and social burden. Particularly
acute exacerbations of COPD (AECOPD) stand for
high hospitalization and mortality rates, health costs,
accelerated progression of lung function decline and
reduced health-related quality of life [1–3]. Since early
treatment is important for faster recovery and for
reducing the overall burden of exacerbations, delay in
help seeking is of major concern [4, 5]. Providing
patients with antibiotics and/or oral corticosteroids
and education about prompt initiation of treatment
when experiencing deteriorating symptoms, appears a
reasonable strategy to handle this concern.
While such self-treatment is obviously effective for
some patients [6–8], high non-adherence rates and even
higher mortality rates in patients with self-treatment
plans [9] have been reported. Moreover, even though
both COPD patients and health care professionals seem
positive about the concept of AECOPD self-treatment
[10, 11], concerns have been raised in terms of choosing
the appropriate patients, and the importance of educa-
tion and ongoing communication has been emphasized
[11, 12]. As self-treatment of AECOPD is often studied
as part of comprehensive self-management programs,
their explicit role within these programs is difficult to
determine [13]. Moreover, beyond the knowledge that
limited education is obviously not sufficient to turn
COPD patients into effective self-treaters [13], it remains
unclear whether self-treatment of AECOPD itself could
compose an effective intervention in routine care and
what is required to ensure successful implementation in
everyday practice. Despite these gaps in knowledge,
AECOPD self-treatment with antibiotics and/or oral cor-
ticosteroids is already recommended in some COPD
guidelines [14, 15].
If we want to establish self-treatment of AECOPD as part
of everyday, routine COPD care, it is important to gain
understanding of the patients’ perspective, as this could
help identify potential barriers to successful implementa-
tion. So far, existing studies on the patients’ perspective on
AECOPD and self-treatment can only give limited insight
into how COPD patients would actually make use of self-
treatment plans. Underlying reasons for their self-treatment
behaviour are little understood [11, 16–19]. This study of
COPD patients’ experiences with, and perspectives on,
AECOPD self-treatment aimed specifically at how patients
decide on the right moment to start treatment with
antibiotics and/or oral corticosteroids when experiencing
worsening symptoms, what they consider important when
making this decision and what aspects might interfere
with the successful implementation of AECOPD self-
treatment in routine care.
Methods
Methodology
The aim of the study required a qualitative study design
suitable for acquiring information about participants’ ex-
periences and meanings. We chose semi-structured in-
depth interviews to get hold of the participants’ stories.
We based our study on the assumption that behaviour
in a situation of ill health is more than a reaction to
physical symptoms resulting from a biological process;
rather, we assume that it results from interpretative
processes stimulated by social interaction through which
persons give meaning to their experiences and social
encounters [20].
Sampling and materials
This study aimed at exploring the perspectives of COPD
patients who have received antibiotics and/or oral cortico-
steroids as part of everyday, routine care, and not as part of
comprehensive self-management programs. We recruited
participants via the responsible physician at a heart-and-
lung rehabilitation institution in northern Norway, who
sent invitation letters to 122 COPD patients in two rounds
(74 in the first round and 48 in the second round). They
had taken part at least once in a 4-week lung rehabilitation
program in 2012/2013, during which patients get informa-
tion about AECOPD but are not systematically instructed
in AECOPD self-treatment. We asked them to note on the
consent form whether they had received any type of medi-
cation they should use when experiencing a worsening of
their COPD. We received 45 signed consent forms and one
email with written consent. Three invitation letters were
returned because of an unknown address and two other
invited participants had passed away. In a first round, we
contacted 15 of the 46 respondents by phone, obtained oral
consent and arranged a date and time for the interviews.
This sampling was done purposefully to include partici-
pants from rural and urban areas, both sexes and with
different working status. Originally, the study aimed at ex-
ploring self-treatment of AECOPD in a broader sense, in-
cluding non-medical self-care activities, which is why we
also included seven participants who had not received anti-
biotics and/or oral corticosteroids. These interviews added
analytic insight on living with AECOPD and help seeking,
but not so much on self-care activities and especially not
on self-treatment with antibiotics and/or oral corticoste-
roids - as these seven participants had not received these.
Therefore, after thorough reflection, we decided to narrow
down the study aim to particularly explore self-treatment
with antibiotics and/or oral corticosteroids, considering
that in-depth knowledge about the self-treatment with
antibiotics and/or oral corticosteroids presented itself
as significant topics of concern, compared to broader,
more general insights into COPD patients’ self-care be-
haviour. In other words, we decided to report mainly
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from a larger subsection of the data. We supplemented
this new approach with another four interviews with
respondents who had received antibiotics and/or oral
corticosteroids (after the second round of invitation
letters). After 19 interviews in total and intermediate
analysis of these, we found we had obtained saturation
[21] in terms of having a rich dataset to answer the
altered research question without new topics emerging
from further data collection. See Fig. 1 for an overview
of the sampling and data collection process.
The interviews took place in participants’ homes (or in
two cases at the University of Tromsø) and lasted between
60 and 120 min. All were conducted by the first author (a
general practitioner trainee and PhD fellow), supervised
by the last author between interviews, and followed an
interview guide with the same key-questions in all inter-
views (see Additional file 1). Focus was on recognition of
exacerbations, self-help activities, experiences with and
reasons for using antibiotics and/or oral corticosteroids,
attitudes towards being a “self-treating” person, and expe-
riences and perspectives on seeking help from health pro-
fessionals when experiencing a worsening of their COPD.
A carefully trained research assistant transcribed the
interviews verbatim from audio recordings. The partici-
pants received a gift coupon of 500 Norwegian krone as
compensation for participation.
Data analysis
We employed thematic analysis [22] and an inductive
approach for data analysis. Nvivo 10 data analysis software
[23] and Mindjet MindManager Professional [24] were used
as tools to organize the transcripts, codes, memos and rela-
tionships between them, and to visualize our findings.
During data collection, interviews were read consecutively
with an analytic view to emerging patterns, something
which resulted in doing 4 more interviews than originally
planned. In the first step of the actual thematic analysis, the
19 transcripts were read by the first and last author to
obtain an overall impression. As a next step, the first author
developed codes from the 12 interviews of those partici-
pants who had received antibiotics and/or oral corticoste-
roids. Due to the revised study aim, the remaining seven
interviews were not coded or used for supporting the
results section, but supplemented the analysis in terms of
showing similar patterns on living with AECOPD and help
seeking as the main 12 interviews (see Table 1). Coding was
done on a semantic level, focusing on experiences and
actions as well as related thoughts, attitudes and motives
relevant for identifying recurrent patterns in the data.
Codes were constantly verified by going back to the data.
The last author reviewed the codes and related data
extracts, and disagreements were clarified by discussion be-
tween the first and last author as well as by occasional re-
coding during the analytic process. Subsequently, the first
author examined relations between the codes in terms of
motives, conditions and consequences of actions and
looked for potential hierarchies to develop preliminary
themes. These comprised patients’ experience from earlier
exacerbations, concerns about medications and interaction
with health care professionals. In order to minimize per-
sonal bias, moving from codes to preliminary and then to
the final themes included constant reflections, literature
reading and discussions with the other authors and peers.
Moreover, themes were constantly tested by moving be-
tween the data, codes and visual theme maps to ensure that
they represented the meanings found in the data and their
explanatory power [17].
Results
Our analysis revealed three overarching themes relevant
to the participants’ decision-making about self-treatment
with antibiotics and/or oral corticosteroids. “Knowing their
Fig. 1 Flowchart showing the recruitment and sampling process
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own body and illness” describes the routine with which all
participants used their personal experiential knowledge
when assessing and responding to deteriorating symp-
toms. “Negotiating the necessity of strong medications” illu-
minates that deciding to start self-treatment requires, in
addition to mere symptom recognition, an assessment of
whether symptoms are serious enough to condone the risk
related to potential adverse effects of the self-treatment
medications. Finally, “Experiencing the limitations of lay-
medical competence” gives insight into how differences in
making use of the self-treatment medications and in help
seeking is linked to aspects of participants’ earlier experi-
ences with health care professionals and relationship to
doctors.
Knowing their own body and illness
Most of the participants did not remember when or how
they obtained the self-treatment medications for the first
time, or the instructions for using them. However, all
seemed to have understood that they should take them
when “getting worse”. Even though ‘getting worse’ was
experienced differently, predominant symptoms to react
upon were slowly increasing breathlessness and worsening
general condition over several days, eventually accompan-
ied by increased mucus production, more coughing or a
feverish feeling.
“…I recognize this lung illness as it comes with a lot
of mucus, I start coughing and there is a lot of mucus
and so on,…”
(woman, participant 4)
As most participants had lived with COPD for several
years and had experience from earlier episodes often oc-
curring with similar symptom patterns, both emotional
and practical responses to worsening symptoms seemed
quite routine. Becoming sick often encompassed restric-
tions in daily life that could cause frustration. Depending
on what was considered appropriate to relieve the symp-
toms, calming down, taking it slow, using specific
breathing techniques, trying mucus-dissolving tablets or
increasing the dosage of short-acting bronchodilators
were applied as prompt self-help activities.
“…but later on, I learned that, […], taught myself to
calm down when I woke up and couldn’t breathe, get
up and take it slow …
(man, participant 6)
If symptoms clearly indicated more severe illness, or
when these ‘first choice’ procedures failed, participants
would think that stronger treatment, namely antibiotics
and/or oral corticosteroids, could become necessary.
“Now I feel it, now there’s something going on in my
body […] something, now I start freezing, fever goes up
until over 39, then there’s something that is not right,
…”
(woman, participant 16)
Both a vague feeling of embodied knowledge, but also
more objective signs could indicate serious illness. Yet,
participants had different perceptions of when a condi-
tion was serious enough, and of which feelings, signs
and symptoms actually indicated the need for stronger
treatment. Even though objective signs like fever or
coloured sputum seemed to make the decision easier for
some participants, we did not find an overall pattern in
the data showing that the presence of objective signs
was critical for making a straightforward decision.
Interviewer: «When do you start with the treatment?»
Woman: “This exactly is a bit difficult, and I think it
might also be difficult for you doctors. Yeah, because,
am I sick enough? Is this a worsening or just a change
in the weather? I am a bit sensitive for when the
outside temperature goes up and down […]. So, am I
sick enough? Or, can I manage the symptoms without
the medications?
(woman, participant 11)
Table 1 Participant demographics
Participant Sex Age range Civil status Residence FEV1/FVC
1a male 55–59 married urban 32%
2a male 70–74 married rural 98%
3a female 75–79 widow rural 34%
4a female 70–74 married rural 39%
5a male 60–64 partner urban 37%
6a male 65–69 married urban 45%
7a female 60–64 divorced rural 59%
8a male 65–69 single urban 63%
9 male 60–64 married rural n.a.
10 male 70–74 married urban 47%
11 female 65–69 divorced rural 39%
12 female 75–79 married urban 91%
13 female 55–59 single rural 84%
14 male 55–59 single rural n.a.
15 male 65–69 married urban 45%
16a female 70–74 married urban n.a.
17a male 60–64 partner urban 20%
18a male 70–74 widow rural 22%
19a male 60–64 single urban 64%
FEV1/FVC forced expiratory volume in one second/forced vital capacity, n.a. not
available zzzz
a participants who have received antibiotics and/or oral corticosteroids for
AECOPD self-treatment and whose interviews were coded in detail
Laue et al. BMC Family Practice  (2017) 18:8 Page 4 of 10
Rather than regarding certain signs/symptoms as abso-
lute indicators for starting treatment, the overall import-
ant question was whether these were serious enough
relative to the medications’ potency and potential adverse
effects.
Negotiating the necessity of strong medications
The necessity for stronger medications was always asso-
ciated with the wish to avoid certain consequences of
becoming seriously ill, such as unwanted hospitalizations
and extensive breathlessness and exhaustion both in the
short- and long-term. The participants regarded antibi-
otics and/or oral corticosteroids as potent treatments to
prevent these consequences.
“I know my body best, don’t I? I know best that, well,
now I am getting worse, and then it is just good to
have them [the drugs] on standby, they have helped
me so many times…”
(woman, participant 16)
At the same time, many participants could have been
warned of the risks associated with taking medications
from their physicians, or could have heard rumours
about the medications’ downsides. This lay-medical un-
derstanding of the medications’ effects could result in
associations between the medications’ potency and ad-
verse effects or risks due to inappropriate use.
“No, it has to do with the fact that I know prednisolone
makes blood vessels thinner, and, and this tells me that
when blood vessels get thinner it can be much easier to
maybe get a stroke or something, eh, and, you won’t go
around eating this… when you know that there
can be dangerous side effects of some kind, right?”
(man, participant 6)
Even though not all participants had similarly strong
thoughts about the medications as this man, the percep-
tion of the self-treatment medications as ‘double-edged
sword’, and the influence of both the ‘effect’ side and the
‘concern’ side on the decision to start treatment, emerged
as a clear pattern across the dataset.
Positive and seemingly well-functioning AECOPD self-
treatment experiences were connected with a certain self-
confidence to interpret signs and symptoms correctly and
a strong appreciation of the quick symptom relief. Disre-
garding concerns about the medications’ adverse effects
alleviated the decision to start treatment as soon as the
first signs of illness occurred. In contrast, participants
being very sceptical towards drugs in general were more
aware about potential treatment related risks. Certain
signs and symptoms did not easily convince them about
the necessity of the disliked medications. They had
concerns regarding the use of oral corticosteroids and
were afraid this might directly damage bodily structures.
Antibiotics, they thought, had indirect adverse effects
mostly on their own health, such as the diminishing effect
in future exacerbations. Talking about antibiotics in a
general way as below also indicated that the participants
refer to a general public health narrative on antibiotics.
“Yes, no, that’s the point, well, you’d wait a bit before
starting this process, ‘cause it’s a kind of serious process,
to start taking antibiotics.”
Interviewer:” Serious process?”
Man:” Well, yeah, it is kind of serious.”
Interviewer:” Why?”
Man:” eh, you, you shouldn’t abuse antibiotics.
So, you’d wait an extra day to see how it goes
before you start.”
(man, participant 1)
Participants with such strong concerns could have a
high threshold to start self-treatment with antibiotics
and/or oral corticosteroids and seemed to wait with
starting treatment until their condition got very serious
in their opinion. Most participants, however, had a more
moderate stance. Those without very strong concerns
about the medications had more difficulties to weigh the
necessity for treatment up against the risk of leaving
their symptoms untreated. Particularly a combination of
slowly developing signs and symptoms and considerable
concerns about antibiotics and/or oral corticosteroids
could cause insecurity regarding the necessity for treat-
ment, eventually leading to a drawn out decision-making
process. Yet, all participants seemed to have individually
varying perceptions of the right moment to start treat-
ment, depending on e.g. feelings of competency and atti-
tudes towards help seeking.
Experiencing the limitations of lay-medical competence
Despite the treatment related concerns, the partici-
pants shared a principal understanding that the idea
of self-treatment could represent a practical alterna-
tive to potential difficulties with getting an emergency
appointment and to the difficulties of traveling to the
doctor’s surgery when feeling very ill. Moreover, having
effective medications on ‘stand-by’ created an overall
sense of security. However, their stories accounted for
substantial differences in how they regarded them-
selves as ‘self-treating’ persons and how they made use
of their self-treatment opportunity. These differences
seemed closely connected to their prior experiences
with receiving care from a health care professional,
which is particularly evident in stories about when to
consult a doctor for assistance.
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“… you feel that breathing is getting heavier and
maybe feel under the weather, well, this could
indeed mean that you have an infection in your
body.”
Interviewer: “Mmm, and then? Do you think taking
antibiotics or doxycycline yourself, is this…?”
Man: “No, I wouldn’t take it without having a doctor
checking me first, I think this is how it’s supposed to
be.”
(man, participant 5)
This man’s reasoning illustrates an attitude held by a
number of participants who had, with the exception of
when being out of the country, never treated themselves
without having consulted the doctor before. These par-
ticipants seemed neither less able than others to inter-
pret their symptoms, nor extremely concerned about the
medications strengths. They just wanted a confirmation
before starting treatment, as they allocated the expertise
and decisional power about these medications to the
doctor. However, this rather paternalistic understanding
of the doctor-patient relationship did not impede their
active and confident participation in managing ‘their’
illness. Rather, regarding the doctor’s expertise as sup-
plement to their own experiential knowledge reflected a
wish to collaborate with their physician for ensuring
optimal treatment. In contrast, other participants had
treated themselves once or several times in the past.
When symptoms occurred as anticipated according to
certain symptom patterns, treatment seemed to be ef-
fective and was apparently carried out with confidence.
However, even the most confident ‘self-treater’ could
experience treatment failure or insecurity whether treat-
ment with antibiotics and/or oral corticosteroids was
really necessary. In such cases, they reached the limits of
their lay-medical competence and needed professional
help.
“…[if] I, over several days, do not feel and see [that
the treatment helps], well, I can tell very well by
the phlegm when it gets better, then it’s not olive
green anymore. When it’s still olive green, then,
then danger is really ahead. Yes, then one heads
downtown [to the doctor], I promise you (laughs).”
(woman, participant 11)
Participants such as this woman, and those who would
always consult a doctor before starting treatment, regarded
help seeking as natural and basically unproblematic. Other
participants, however, tended to hesitate with consulting a
doctor when feeling insecure or in case of treatment failure.
One underlying reason seemed a desire to ‘bypass’ an
encounter with their doctors by clinging to the self-
treatment opportunity.
“Well, I wouldn’t call [call the doctor] without…
thinking that I needed to go to the hospital to get
some help. I’ve been down [very sick] so many times
that, that, well, I’ve always got up on my feet again,
but it’s, it takes often quite a long time to get better.”
(man, participant 18)
Several participants who trusted their own knowledge
more than, or at least as much as, the doctors’ expertise,
shared this man’s attitude that doctors had not more
help to offer than they could provide for themselves.
Their stories revealed negative experiences of having re-
ceived care for earlier AECOPD or other illnesses. They
seemed to avoid contact with doctors whenever possible,
even though this would mean a prolonged course of
illness. Their confidence in self-treatment seemed to a
considerable extent be based on distrust in the health-
care system. Other participants actually appreciated the
reassuring care of a doctor when feeling insecure, but
hesitated anyway with seeking help.
“Well, I wish I could [call the doctor]. But it’s so deep
inside me, that… I’m afraid to bother [the doctor], I
don’t want to bother [them], you see?”
Interviewer: “Explain a bit more, will you?”
Woman: “Well, that I should call and call and call
and bother him with the same things, well, I should
know it, after so many years I should know it myself.”
(woman, participant 11)
The reasoning behind their hesitation to seek help
comprised worries of being burdensome to the doctor,
feeling obliged to be able to manage ‘their illness’ on
their own. Instead of regarding insecurity of making a
distinct treatment decisions as a natural limitation of a
layperson’s medical competence, they would perceive it
as personal incapability or failure, eventually keeping
them from timely help seeking.
Discussion
Main results
The present study aimed at exploring the use of AECOPD
self-treatment with antibiotics and/or oral corticosteroids
from the patients’ perspective, focusing on aspects rele-
vant to their decision of when to start treatment and on
potential barriers to more successful implementation of
this care strategy. We found that the decision to start self-
treatment required not only symptom recognition but also
symptom assessment in terms of evaluating whether the
illness was serious enough to condone the treatment re-
lated risks. This assessment could be easy when symptoms
occurred according to the patients’ regularly experienced
symptom patterns, and clearly indicated that treatment
with antibiotics and/or oral corticosteroids was the best
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alternative for symptom relief. Yet, when signs and symp-
toms were ambiguous, or in case of treatment failure,
assistance by a medical professional could be necessary.
Help seeking, though, could be, but was not always
natural to all participants. Distrust in receiving appropri-
ate care, or feeling obliged to succeed with self-treatment
could be barriers to timely help seeking when needed.
Strengths and limitations
Our purposeful sample ensured that all the participants
had a comparable level of education about COPD through
the rehabilitation program. Perspectives from both sexes
and different age groups, working status, residence and
different sources of the self-treatment medications
ensured considerable variation in the sample. This is a
strength of our study, as it enables us to acquire insight
into COPD patients’ real-life experiences, rather than
depicting idealized self-treatment strategies as described
in the literature and in policy statements. Yet, this has
implications for the transferability of our findings. On the
one hand, this study adds valuable knowledge to inform
actors involved in implementation of AECOPD self-
treatment into routine care, such as primary care physi-
cians. On the other hand, transferability to COPD patients
receiving more comprehensive instructions about self-
treatment, as for instance in randomized self-treatment
trials, might be limited. Another limitation is that partici-
pants may in some cases have not talked about AECOPD
in a medical sense, but about illness episodes assumed to
be exacerbations resulting in actions such as self-
treatment or seeking help from health care professionals.
Choosing another sampling strategy that ensured that
participants had been diagnosed with AECOPD would
perhaps have resulted in other findings. However, we
considered our method more appropriate because self-
treatment also includes self-diagnosis rather than diagno-
sis by a professional. Furthermore, we acknowledge that
adjusting the study aim and subsequently, the approach to
data collection, during the study period is debateable in
terms of sampling bias. Yet, we regard our choice as
appropriate according to our experiences and reflections
during the data collection process.
Discussion of the main results
Our findings that COPD patients have considerable
experience-based knowledge and skills to recognize and
promptly respond to symptom changes are in line with
the results of previous studies [17, 19, 25, 26]. Self-
treatment with antibiotics and/or oral corticosteroids may
in fact compose a practical alternative to traditional care,
particularly for patients with recurrent symptom patterns
clearly indicating when treatment beyond increased dos-
age of maintenance treatment or non-medical self-help is
necessary. ‘Knowing the patient‘, in terms of knowing their
usual presentation during an exacerbation, seems there-
fore important to identify patients potentially benefiting
from self-treatment [11, 27]. The importance of individu-
alizing treatment plans is already widely recognized and
implemented in self-treatment interventions [6, 28]. How-
ever, this disease-focused approach to self-treatment edu-
cation does not consider the patients’ perception of and
attitude towards utilizing ‘their’ plans.
One of our main findings was that the decision to start
self-treatment with antibiotics and/or oral corticoste-
roids always included an evaluation of whether leaving
the illness untreated composed a greater health risk than
the potential side effects of the medication. Especially
when symptoms were diffuse and not clearly indicated
the need for treatment, we found that patients would
hesitate with starting treatment or not start treatment at
all by themselves. COPD patients’ concerns regarding
the self-treatment medications appear in earlier studies,
but are often not further discussed as a key to patients’
self-treatment decision-making [16, 17]. Yet, patients’
double-edged perspectives on drugs in general and their
influence on medication taking behaviour has long been
understood [29–35].
According to the Necessity-Concerns-Framework, for in-
stance, treatment cognitions are equally important as ill-
ness cognitions to determine patients’ treatment-related
decision-making. Its core concept comprises a “necessity-
concern-dilemma”, which describes a patient’s judgement
about the personal need for treatment as opposed to con-
cerns about potential negative consequences [34]. Even
though the Necessity-Concerns-Framework is an extension
of Leventhal’s Common Sense Model of Illness Representa-
tions [36], which is regularly brought up in the COPD self-
management literature, the framework remains to our
knowledge unnoticed in the theoretical foundations of
COPD self-management interventions [37]. Treatment
cognitions are important in our study, yet, we do not know
to what extent patients’ treatment related concerns in fact
contribute to inappropriate treatment decisions in a
medical sense, or whether patients with less concerns
and clearer symptoms are those with better outcomes
in self-treatment interventions.
Importantly, our results clearly show that patients can
feel uncertain about symptoms and treatment necessity or
may experience treatment failure. They might over-or
underestimate the necessity for treatment with antibiotics
and/or oral corticosteroids according to what is appropri-
ate from a medical point of view. Therefore, as clinical
examination and diagnostic tests can help to better target
AECOPD treatment to the underlying cause, involving a
health care professional in the assessment of AECOPD
would at least make sense if symptoms are ambiguous.
Yet, our findings suggest that patients’ decisions regarding
self-treatment and help seeking are not motivated by pure
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medical aspects, but mostly by their previous encounters
with doctors and experiences with the health care system.
This raises questions regarding the ‘real’ impact of self-
treatment interventions on patients’ behaviour. In theory,
self-treatment education should increase patients’ self-
efficacy in interpreting their symptoms, contribute to
patient autonomy and to less need for health care contacts
[37, 38]. Even though these goals may have partly been
reached, the overall evidence remains inconclusive [38].
According to sociologically inspired investigations on
health care utilization of people with chronic illnesses, it is
clearly the recursive nature of health care contacts
throughout a patient’s individual illness trajectory that
determines current and future health care utilization
patterns [39–41]. Neither changes in the delivery of
health care nor the “expressed need” for help were
found to predict a patient’s self-care and help seeking
behaviour [40, 41]. This understanding is reflected in
our participants’ help seeking attitudes. Participants
principally contacting their doctor before starting treat-
ment did not seem to have adopted self-treatment as a
new form of AECOPD care even though their experien-
tial and lay-medical knowledge was probably sufficient
to negate the need for help in the first place. Moreover,
we argue here that participants who in fact used their
self-treatment medications did so because the self-
treatment opportunity served to maintain their already
existing pattern of interacting with the health care system.
Importantly, the introduction of new means of health care,
such as AECOPD self-treatment, might even threaten pa-
tients’ established relation to health care professionals and
result in tensions unsupportive of the implementation of
these new care forms [42]. We find that such a tension is
reflected in participants who felt uneasy to contact their
doctor due to the feeling that they should be able to man-
age AECOPD self-treatment on their own. Engaging in
self-treatment to avoid contact with a doctor or due to
worries of being burdensome would then, at least partly,
derive from a dysfunctional patient-physician relationship
instead of a patients’ medical confidence. On the one
hand, this may raise concerns regarding the increased use
of antibiotics and oral corticosteroids, which was found in
patients in self-treatment intervention groups [43–45]. On
the other hand, patients engaging in self-treatment or
hesitating to contact the doctor would be consistent with
other findings showing that a number of self-treatment
interventions reduced the number of health care contacts
[44–47].
The above discussion mirrors further the results
from a study suggesting that self-care and help seeking
patterns of people with chronic illnesses are “intrinsic-
ally intertwined” and result from a dynamic relation-
ship between life-world experiences and experiences
from illness trajectories [39]. This understanding
implies that patients make appropriate and logical
decisions according to their lay-medical understanding
of illness and medications, and the impact of symp-
toms on their daily living. While COPD patients’ mo-
tivation to engage in self-treatment or to seek help
might express their ‘voice of the lifeworld’, caregivers
and policy makers may promote self-treatment with
‘the voice of medicine’ [48]. Listening closer to the
patients’ voice, that is acknowledging their basic con-
cerns, patterns of relationships to health care and ex-
periences from everyday management of their illness,
could help caregivers to identify discrepancies between
their own and the patients’ motivations for AECOPD
self-treatment [48, 49]. This could help to overcome
potential barriers to the implementation of AECOPD
self-treatment with antibiotics and/or oral corticosteroids
in routine care, and would strengthen the understanding
of COPD self-management, including AECOPD self-
treatment, as one element of integrated care instead of
regarding it as the ultimate goal in itself [50, 51].
Conclusions
AECOPD self-treatment can be a valuable alternative to
traditional care, especially for COPD patients with
recurring AECOPD symptom patterns. Yet, to start
treatment with antibiotics and/or oral corticosteroids
is not a straightforward decision purely based on
signs and symptoms. The patients take their previous
experience into account and, like doctors, balance
benefits and risks related to the potent medication.
Moreover, patients’ attitudes and preferences regarding
self-treatment and interaction with health care profes-
sionals are influencing patients’ decision to seek help
when needed. We suggest that giving patients the re-
sponsibility to self-manage potentially severe illnesses
such as AECOPD should be regarded as supplemen-
tary to care by a health care professional. Moreover,
AECOPD self-treatment should follow a collaborative
approach, comprising a medical and social dimension.
That is, caregivers should consider patients’ experien-
tial knowledge about their AECOPD symptoms
patterns when choosing eligible patients for self-
treatment (medical dimension). Moreover, when tai-
loring self-treatment plans for individual patients,
caregivers should try to determine patients’ under-
standing of and preferences for self-treatment as a
means of health care (social dimension), including
thoughtful and respectful communication about
medication-related concerns and potential barriers to
help seeking. This could help practising clinicians to
establish and maintain a collaborative relationship
with their patients and to improve the implementation
of AECOPD self-treatment in routine care.
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did not necessarily ask the questions as they appear in the interview
guide, but adapted the questions in every interview. The interviewer was
mainly guided by the four main topics that can be found as underlined
headings in the interview guide. (PDF 102 kb)
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